TLDR
- Oracle reports fiscal Q4 2026 earnings after the bell on Wednesday, June 10
- BofA raised its price target to $240 from $200, keeping a Buy rating
- Citi analyst Tyler Radke raised his target to $330, implying ~56% upside from current levels
- The stock has risen ~48% over the past two months but pulled back ~13% in the past week
- Wall Street consensus is a Strong Buy based on 28 Buys vs. 5 Holds, with an average target of $268.44
Oracle is trading around $211.82 ahead of its fiscal fourth-quarter 2026 earnings report, due after the close on Wednesday, June 10.
The stock has climbed roughly 48% over the past two months but slipped about 13% over the last week, reflecting broader market volatility heading into the print.
BofA Securities raised its price target on Oracle to $240 from $200 on Monday, maintaining its Buy rating. The firm said the rally since Q3 earnings has been driven largely by broader software strength and eased funding concerns, following around $50 billion in recent debt and equity raises.
The new BofA target is based on 26.5 times its calendar year 2027 earnings estimate, up from the 22 times multiple used previously.
What Analysts Are Watching
Citi analyst Tyler Radke is more bullish. He raised his price target to $330 from $320, implying roughly 56% upside from current levels, and kept his Buy rating.
Radke expects Oracle to post revenue and profitability toward the upper end of its guidance range. He also sees IaaS growth remaining on track, with strong OCI performance helping to offset softer SaaS results.
For the quarter, Radke forecasts net new remaining performance obligations (NNRPO) to approach $600 billion, supported by broad demand across cloud infrastructure.
Looking ahead to fiscal Q1, he expects cloud guidance to imply around 60% growth, with capital expenditure potentially exceeding $80 billion in fiscal 2027.
Evercore ISI projects Q4 revenue of $19.0 billion, a 19.5% year-over-year increase, and EPS of $1.95 — just below the $1.96 consensus.
More Targets, More Optimism
TD Cowen has a $300 price target. Oppenheimer sits at $275. Evercore ISI is at $245. Barclays has an Overweight rating with a $240 target.
Guggenheim is the most bullish of the group, maintaining a Buy with a $400 price target, pointing to Oracle’s recent capital raise and the substantial OpenAI funding round as positive indicators.
Oracle currently trades at a P/E ratio of 38. BofA’s InvestingPro data rates the company’s overall financial health as “GOOD” at 2.56, though it flags the stock as potentially overvalued relative to its Fair Value estimate.
The Street average target sits at $268.44, offering roughly 27% upside from current levels. The analyst consensus, based on 28 Buys and 5 Holds, rates ORCL a Strong Buy.
Oracle last reported a stock gain of 30% since its Q3 fiscal 2026 earnings, and 45% since BofA reinstated coverage in March.
🚨 Our MAY Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for May, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!
Be the first to comment